Search Within

Heiko Schoder

  1. "Radiation Oncology, Department of"
Formats
  1. Journal Article (67)
  2. Meeting Abstract (65)
  3. Research Letter (2)
  4. Conference Paper (1)
Groups
  1. Molecular Imaging and Therapy Service (135)
  2. Radiation Oncology, Department of (135)
  3. Radiology, Department of (135)
  4. Department of Medicine (90)
  5. Survivorship Research (86)
  6. Center for Hematologic Malignancies (56)

More Groups

People
  1. Nancy Lee (65)
  2. Joachim Yahalom (50)
  3. John Humm (42)
  4. Maria Palomba (39)
  5. Ariela Noy (34)
  6. Alison Moskowitz (33)

More People

Years
  1. 2025 (4)
  2. 2024 (14)
  3. 2023 (16)
  4. 2022 (9)
  5. 2021 (11)
  6. 2020 (8)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (39)
  2. Blood (20)
  3. Journal of Clinical Oncology (14)
  4. Journal of Nuclear Medicine (9)
  5. Hematological Oncology (6)
  6. Blood Cancer Journal (3)

More Publications

Publishers
  1. Elsevier Inc. (46)
  2. American Society of Hematology (22)
  3. American Society of Clinical Oncology (14)
  4. Society of Nuclear Medicine (9)
  5. Wiley Blackwell (8)
  6. Springer (5)

More Publishers

Results (135)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safety and feasibility of PARP1/2 imaging with (18)F-PARPi in patients with head and neck cancer
    Journal Article

    Schöder, H.; De Souza Franca, P. D.; Nakajima, R.; Burnazi, E.; Roberts, S.; Brand, C.; Grkovski, M.; Mauguen, A.; Dunphy, M. P.; Ghossein, R. A.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Rosai-Dorfman disease - Utility of (18)F-FDG PET/CT for initial evaluation and follow-up
    Journal Article

    Mahajan, S.; Nakajima, R.; Yabe, M.; Dogan, A.; Ulaner, G. A.; Yahalom, J.; Noy, A.; Diamond, E. L.; Schöder, H.
    Clinical Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • Long-term follow-up confirms durability of single-agent brentuximab vedotin as pre-transplant salvage for classical Hodgkin lymphoma
    Meeting Abstract

    Moskowitz, A. J.; Schoder, H.; Lee, J.; Davey, T.; Hancock, H.; Hamlin, P. A.; Horwitz, S. M.; Kumar, A.; Matasar, M. J.; Noy, A.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • High complete response rate observed with second-line chemo-immunotherapy with pembrolizumab and GVD (gemcitabine, vinorelbine, and liposomal doxorubicin) in relapsed and refractory classical Hodgkin lymphoma
    Meeting Abstract

    Moskowitz, A. J.; Shah, G. L.; Schoder, H.; Hancock, H.; Davey, T.; Joong, C.; Pomerantz, L.; Jarjies, C.; Kumar, A.; Lahoud, O. B.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • A pilot study of brentuximab vedotin combined with AVD chemotherapy and radiotherapy in patients with newly diagnosed early stage, unfavorable risk Hodgkin lymphoma
    Meeting Abstract

    Kumar, A.; Casulo, C.; Advani, R. H.; Budde, L. E.; Barr, P. M.; Batlevi, C. L.; Caron, P.; Constine, L. S.; Dandapani, S.; Drill, E.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Phase III multi-center, prospective randomized trial comparing high dose single fraction radiation therapy to a 3-fraction SBRT regimen in the treatment of oligometastatic human cancer
    Meeting Abstract

    Zelefsky, M. J.; Yamada, Y.; Lis, E.; Schoder, H.; Lochansingh, S.; Shi, W.; Zhigang, Z.; Braunstein, S. E.; Kolesnick, R.; Fuks, Z.
    International Journal of Radiation Oncology, Biology, Physics (2018)

    Fulltext@MSK | Save
  • Uptake of [(18)F]fluorodeoxyglucose in initial positron-emission tomography predicts survival in MALT lymphoma
    Journal Article

    Qi, S.; Huang, M. Y.; Yang, Y.; Schöder, H.; Teckie, S.; Noy, A.; Chau, K.; Yahalom, J.
    Blood Advances (2018)

    Fulltext@MSK | Save
  • Predicting hypoxia status using a combination of contrast-enhanced computed tomography and (18)F-fluorodeoxyglucose positron emission tomography radiomics features
    Journal Article

    Crispin-Ortuzar, M.; Apte, A.; Grkovski, M.; Oh, J. H.; Lee, N. Y.; Schöder, H.; Humm, J. L.; Deasy, J. O.
    Radiotherapy and Oncology (2018)

    Fulltext@MSK | Save
  • A personalized approach using hypoxia resolution to guide curative-intent radiation dose-reduction to 30 Gy: A novel de-escalation paradigm for HPV-associated oropharynx cancers (OPC)
    Meeting Abstract

    Riaz, N.; Sherman, E. J.; Katabi, N.; Leeman, J. E.; Higginson, D. S.; Boyle, J.; Singh, B.; Morris, L. G.; Wong, R. J.; Tsai, C. J.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A pilot study of brentuximab vedotin and AVD chemotherapy followed by 20 Gy involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma
    Meeting Abstract

    Kumar, A.; Casulo, C.; Advani, R. H.; Budde, L.; Barr, P. M.; Batlevi, C. L.; Caron, P.; Chen, R. W.; Constine, L. S.; Courtien, A.; more...
    Blood (2017)

    Fulltext@MSK | Save